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Abstract
Background: Cholera remains a major global health challenge. Uvira, in the Democratic Republic of the Congo
(DRC), has had endemic cholera since the 1970’s and has been implicated as a possible point of origin for national
outbreaks. A previous study among this population, reported a case confirmation rate of 40% by rapid diagnostic
test (RDT) among patients at the Uvira Cholera Treatment Centre (CTC). This study considers the prevalence and
diversity of 15 enteric pathogens in suspected cholera cases seeking treatment at the Uvira CTC.
Methods: We used the Luminex xTAG® multiplex PCR to test for 15 enteric pathogens, including toxigenic strains
of V. cholerae in rectal swabs preserved on Whatman FTA Elute cards. Results were interpreted on MAGPIX® and
analyzed on the xTAG® Data Analysis Software. Prevalence of enteric pathogens were calculated and pathogen
diversity was modelled with a Poisson regression.
Results: Among 269 enrolled CTC patients, PCR detected the presence of toxigenic Vibrio cholerae in 38% (103/269)
of the patients, which were considered to be cholera cases. These strains were detected as the sole pathogen in
36% (37/103) of these cases. Almost half (45%) of all study participants carried multiple enteric pathogens (two or
more). Enterotoxigenic Escherichia coli (36%) and Cryptosporidium (28%) were the other most common pathogens
identified amongst all participants. No pathogen was detected in 16.4% of study participants. Mean number of
pathogens was highest amongst boys and girls aged 1–15 years and lowest in women aged 16–81 years. Ninety-
three percent of toxigenic V. cholerae strains detected by PCR were found in patients having tested positive for V.
cholerae O1 by RDT.
Conclusions: Our study supports previous results from DRC and other cholera endemic areas in sub-Sahara Africa
with less than half of CTC admissions positive for cholera by PCR. More research is required to determine the
causes of severe acute diarrhea in these low-resource, endemic areas to optimize treatment measures.
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Background
In 2016, infectious diarrheal diseases were estimated to
be the eighth leading cause of global mortality, attribut-
ing to 1.6 million deaths, and the third leading cause of
disability-adjusted life years (DALYs) [1]. Diarrheal mor-
bidity and mortality are concentrated in low and middle-
income countries (LMICs) with the highest burden in
South Asia and Sub-Sahara Africa (SSA) [2]. Children
under five years of age bear most of this burden with
diarrheal diseases in early life often leading to malnutri-
tion, growth faltering, cognitive shortcomings, and vita-
min deficiencies [2–4].
Diarrheal diseases of infectious origin are predominantly
caused by enteric pathogens (including bacteria, viruses,
protozoa, and fungi) that are transmitted by oral-fecal
routes via ingestion of contaminated food, water or via
dirty fingers or fomites, and shed in human and animal
feces [5]. Diarrhea caused by the bacterium Vibrio cho-
lerae is of particular global concern. In 2015, cholera was
endemic in over 47 countries and outbreaks continue to
resurface in conflict zones and after natural disasters, such
as the outbreaks previously seen in Yemen, South Sudan
and Haiti [6, 7]. Severe cholera illness is identified by
symptoms of severe dehydration and acute watery diar-
rhea, defined as three or more loose liquid stools in 24 h,
and if untreated, can be fatal within hours of symptom on-
set [8]. During the first few hours of symptom onset, chol-
era can be hyper-infectious and person-to-person
transmission can increase [9]. However, a large proportion
of infections remain asymptomatic and carriers still shed
V. cholerae but at a lower dose [10]. Cholera particularly
affects areas with limited drinking water and sanitation in-
frastructure [7]. Globally, the highest incidence of cholera
is reported in inland Sub-Sahara Africa, particularly in
Eastern Democratic Republic of the Congo (DRC) and
Western Uganda regions [11, 12].
In 2017, the Global Task Force for Cholera Control
(GTFCC) launched a new “Global Roadmap” to reduce
cholera mortality by 90% globally and to eliminate chol-
era in as many as 20 countries by 2030 [8]. This new
global strategy led by WHO has three components: (1)
early detection and response to outbreaks; (2) a multi-
sectoral approach targeting cholera “hotspots”; and (3)
effective coordination of support efforts at local and glo-
bal levels. Comprehensive efforts to control cholera in-
clude: ensuring access to safe drinking water and
sanitation, and associated hygiene practices; effective
treatment for patients, including oral, or intravenous re-
hydration therapy; and antibiotic treatment for severe
cases. In addition to these interventions, safe and effect-
ive oral cholera vaccines (OCV) are now available and
recommended in many settings [13, 14]; although timely
distribution can be challenging due to limited global
stockpiles, and the security and logistical challenges in-
herent to many cholera-affected areas [6, 14, 15].
As part of an ongoing trial (the “Uvira Trial”) to evalu-
ate the impact of improved piped water supply in Uvira
on cholera and other diarrheal diseases started in 2016,
our study investigates enteric pathogens among sus-
pected cholera patients admitted to a Cholera Treatment
Centre (CTC) in Uvira, DRC using a commercial multi-
plex polymerase chain reaction (PCR) on rectal swabs
collected over a nine-month period. The specific objec-
tives are to: (1) quantify the prevalence of enteric patho-
gens among suspected cholera cases; (2) describe the
diversity of enteric pathogens among these patients; and
(3) compare confirmation of cholera by PCR and rapid
diagnostic test (RDT) methods.
Methods
Study setting
Uvira is a city within the province of South Kivu on the
eastern side of the DRC along the shores of Lake Tan-
ganyika in the African Great Lakes region with an esti-
mated 233,000 inhabitants in 2017 [16]. Decades of
protracted conflict resulting in population displacement
combined with limited public health infrastructure have
hampered national and international efforts for cholera
control in eastern DRC [17]. The African Great Lakes
region has been implicated in the spread of outbreaks to
other parts of the country and Uvira, in particular, has
had endemic cholera since the 1970s [18]. The only
CTC in Uvira is located within the district hospital to
provide appropriate free treatment for all patients pre-
senting acute diarrhea, defined as: three or more loose/
water stools within 24 h [19]. All cases admitted are re-
ported as cholera cases in the National Health Informa-
tion System (NHIS) and are treated by national protocol
for suspected cholera, receiving rehydration therapy and,
occasionally, broad-spectrum antibiotics, zinc, or alben-
dazole [19]. A recent linked study to confirm cholera
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cases by RDT among patients at the Uvira CTC found
that only 40% tested positive [19].
Sampling strategy and data/sample collection
The sampling and recruitment procedures have been de-
scribed previously [19]. In brief, basic demographic and
clinical information for each participant were extracted
from CTC patient records, including: age, sex, location
of residence, date of admission, date of discharge or
transfer, symptoms, and whether the patient received an-
tibiotics prior to rectal swab collection and, if so, the
number of hours between first dose and the rectal swab
collection. All data were anonymized and entered onto a
password-protected tablet by trained researchers and
then uploaded to a secure Open Data Kit (ODK) server,
and the data then deleted from the tablet.
A trained laboratory technician collected a rectal swab
for all new, consenting patients in the morning, seven
days a week. The rectal swab was then immediately
eluted in 1ml sterile physiological water for approxi-
mately 10 s and lightly shaken before a part is trans-
ferred to alkaline peptone water (APW) for an
enrichment stage of 6 h before Crystal VC RDT testing
(Crystal VC, Span Diagnostics, Surat, India). In parallel,
four drops of physiological water (each approximately
40 μl) were preserved on Whatman FTA Elute cards (GE
Life Sciences, Piscataway, NJ USA). Once dry, the cards
were stored at room temperature in an individual zipped
plastic pouch containing a 1 g packet of desiccant silica
gel. Previous studies evaluated Crystal VC RDT sensitiv-
ity and specificity to be 92 and 91%, respectively [20]
and confirmed the effectiveness of Whatman FTA Elute
cards (GE Life Sciences, NJ USA) for preservation of nu-
cleic acid for future multiplex PCR analysis [21]. The
preserved samples were shipped to the London School
of Hygiene and Tropical Medicine for laboratory analysis
under the UN3373 infectious substance EXEMPT regu-
lations and under a Material Transfer Agreement
(MTA) with the Ministry of Health for DRC.
Laboratory analysis: DNA extraction and PCR
The Luminex xTAG® Gastrointestinal Pathogen Panel
(GPP) was used to analyze the FTA Elute cards for the
presence of 15 enteric pathogens: adenovirus, Campylo-
bacter, Clostridium difficile, Cryptosporidium, Entamoeba
histolytica, Escherichia coli O157, Enterotoxigenic Escheri-
chia coli (ETEC) LT/ST, Giardia, norovirus GI/GII, rota-
virus A, Salmonella, shiga toxin-producing Escherichia
coli (STEC), Shigella, toxigenic Vibrio cholerae, and Yersi-
nia enterocolitica (Luminex Corporation, Austin TX,
USA) [22]. The GPP kit is a validated [23–25] commercial
real-time PCR assay for the stool-based detection of these
pathogens and has been used in various settings [26, 27].
Nucleic acid was extracted from the Whatman Elute
Cards using the GE Healthcare Life Sciences protocol (NJ
USA) [28]. We added one μL of bacteriophage MS2, the
internal control provided by xTAG® GPP to each sample
during the wash stage of extraction process, as advised by
Luminex®. PCR amplification and hybridization were con-
ducted according to the supplier’s protocol (Luminex Cor-
poration, Austin TX, USA). Results were interpreted on
MAGPIX® and analyzed on the xTAG® Data Analysis Soft-
ware (Luminex Corporation, Austin TX, USA).
Statistical analysis
All statistical analyses were conducted in STATA ver-
sion 15 (Stata Corporation, College Station, TX, USA).
The prevalence, and corresponding 95% confidence in-
tervals, for detected enteric pathogens were calculated
and stratified by a demographic group, combining both
sex and age groups. Poisson regression for count data
was used to describe the diversity of enteric pathogens
stratified by the demographic group. Robust standard er-
rors were used to control for minor variations from
underlying assumptions [29]. The deviance χ2 and Pear-
son χ2 goodness of fit tests were used to determine
whether data fitted a Poisson distribution. The incident
rate ratios (IRR) were recorded along with correspond-
ing p-values for a two degrees-of-freedom test. Univari-
ate logistic regression was used to determine if the age
and sex demographic group was associated with V. cho-
lerae detection. Antibiotic treatment prior to sample col-
lection was identified as a potential source of bias a
priori as a single dose of antibiotics can be absorbed in
the body in as few as 3 h [30] and, therefore, included in
both Poisson and logistic regressions to assess if anti-
biotic administration influenced the statistical analysis.
Crystal® VC RDT (Span Diagnostics, Surat, India) de-
tects O1/O139 antigens of V. cholerae strains whereas
the Luminex xTAG® GPP targets the ctx gene coding for
the cholera toxin, therefore detecting toxigenic V. cho-
lerae strains. Discordant pairs for cholera RDT and
multiplex-PCR with elute cards were identified. The
McNemar χ2 test was used to test for marginal homo-
geneity between these two diagnostic methods.
There were no missing data for any statistical analyses.
The corresponding anonymized raw data can be found
in Additional File 1.
Results
Characteristics and demographics of study participants
Between 24 September 2017 and 09 July 2018, 269 pa-
tients admitted to the CTC were enrolled into the study.
No patients were enrolled into the study between 11 De-
cember 2017 and 11 February 2018 due to a shortage of
supplies. Sixty-three percent of study participants were
over the age of 15. Sex was evenly distributed amongst
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study participants (female n = 132; and male n = 137).
Among the participants, 27 (11%) had received antibi-
otics with a mean time between treatment and sample
collection of 6.26 h. Antibiotic treatment was not associ-
ated with either the mean number of pathogens present
(p = 0.2) or V. cholerae detection (p = 0.3).
Prevalence and diversity of enteric pathogens
Multiplex-PCR detected 37% (100/269) of all samples
were positive for a single pathogen only. Amongst par-
ticipants with only a single pathogen detected, 37 were
V. cholerae, 32 were ETEC, and 22 were Cryptosporid-
ium. The distribution of single pathogen detection is
shown in Fig. 1. Amongst all study participants, 38%
(103/269) were positive for toxigenic V. cholerae with
men 16–81 years being the demographic group with the
highest prevalence at 52%. The other most common en-
teric pathogens detected were Cryptosporidium (28%,
74/269), Enterotoxigenic Escherichia coli (36%, 96/269),
Shigella (16%, 43/269), and Campylobacter (17%, 45/
269). Forty-five percent of participants carried multiple
pathogens (two or more).
Girls 1–15 years had the highest prevalence of carrying
multiple pathogens and a fifth of all boys 1–15 years car-
ried three pathogens. Our study detected one boy aged
1–15 years who tested positive for rotavirus. Our study
could not detect any enteric pathogen for 16% of the
study population. Table 1 refers to the prevalence with
95% confidence intervals of individual pathogens strati-
fied by the demographic group.
Our study participants carried a mean of 1.6 pathogens
per patient and up to eight different pathogens were de-
tected in a single patient (Interquartile range = 1). Boys
and girls 1–15 years carried a greater number of patho-
gens than adults. There was some evidence indicating
boys 1–15 years carried 1.47 (95%CI: 1.13–1.92; p =
0.004) times the number of pathogens than women 16–
81 years. Likewise, girls 1–15 years carried 1.6 (95%CI:
1.27–2.02; p < 0.001) times the number of pathogens
than adult women. Table 2 presents the mean number
of pathogens by demographic groups.
Comparison of cholera detection by stool-based
multiplex-PCR and Crystal VC RDT
Of the 269 study participants, 17 (6%) were RDT-
positive for V. cholerae O1 but negative for toxigenic V.
cholerae via PCR and inversely, 19 (7%) were positive via
PCR but RDT-negative. There was no evidence suggest-
ing a difference in homogeneity (McNemar’s χ2 p =
0.74).
Discussion
All study participants were admitted to the Uvira CTC
with suspected cholera, as defined by acute diarrhea, but
only 38% (103/269) were positive for V. cholerae by rec-
tal swab-based multiplex-PCR analysis. Among the par-
ticipants, 11 different non-cholera enteric pathogens
were detected; of which, ETEC (36%) and Cryptosporid-
ium (28%) were the two most prevalent. Eighty-three
percent of participants had at least one of the 15
assessed pathogens and almost half (45%, 122/269) were
Fig. 1 Frequency of specific enteric pathogens detection among enrolled CTC patients
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Table 1 Prevalence of enteric pathogens by age and sex demographic group
Enteric Pathogen Prevalence (95% Confidence Interval)
Total enrolled Boys 1–15 years Men 16–81 years Girls 1–15 years Women 16–81 years
Total Samples 269 54 83 47 85
At least one pathogen positive 83.6% (78.7–87.6) 85.2% (72.7–92.5) 83.1% (73.3–89.8) 89.4% (76.4–95.6) 80.0% (70.0–87.3)
Bacteria 73.9% (68.4–78.9) 68.5% (54.7–79.7) 75.9% (65.4–84.0) 78.7% (64.4–88.3) 72.9% (62.4–81.4)
Toxigenic Vibrio cholerae 38.3% (32.6–44.3) 25.9% (15.8–39.5) 51.8% (41.0–62.5) 38.3% (25.3–53.2) 32.9% (23.7–43.7)
Enterotoxigenic E. coli 35.7% (30.2–41.6) 40.7% (28.3–54.5) 30.1% (21.1–41.0) 38.3% (25.3–53.2) 36.5% (26.8–47.3)
Campylobacter 16.7% (12.7–21.7) 27.8% (17.3–41.4) 10.8% (5.7–19.7) 29.8% (18.3–44.6) 8.2% (3.9–16.4)
Shigella 16.0% (12.1–20.9) 24.1% (14.3–37.5) 14.5% (8.3–23.9) 23.4% (13.2–37.9) 8.2% (3.9–16.4)
Salmonella 3.7% (2.0–6.8) 3.7% (0.9–14.0) 2.4% (0.6–9.4) 4.3% (1.0–16.0) 4.7% (1.8–12.0)
Escherichia coli O157 2.5% (1.3–5.4) 1.9% (0.2–12.5) 2.5% (0.6–9.5) 6.4% (2.0–18.5) 1.2% (0.1–8.1)
Clostridium difficile 1.9% (0.8–4.4) 1.9% (0.2–12.5) – 2.1% (0.3–14.3) 3.5% (1.1–10.5)
Shiga Toxin-producing E. coli 0.7% (0.2–2.9) – – 2.1% (0.3–14.3) 1.2% (0.02–8.1)
Yersinia enterocolitica – – – – –
Viruses 2.2% (1.0–4.9) 5.6% (1.8–16.2) – 2.1% (0.3–14.3) 2.4% (0.6–9.1)
Adenovirus 40/41 1.1% (0.4–3.4) 1.8% (0.2–12.5) – 2.1% (0.3–14.3) 1.2% (0.2–8.1)
Norovirus GI/GII 0.7% (0.2–2.9) 18.5% (0.2–12.5) – – 1.2% (0.2–8.1)
Rotavirus A 0.4% (0.1–2.6) 1.9% (0.2–12.5) – – –
Parasites 27.5% (22.5–33.2) 35.2% (23.5–49.0) 26.5% (18.0–37.2) 29.8% (18.3–44.6) 22.4% (14.6–32.6)
Cryptosporidium 27.5% (22.5–33.2) 35.2% (23.5–49.0) 26.5% (18.0–37.2) 29.8% (18.3–44.6) 22.4% (14.6–32.6)
Entamoeba histolytica – – – – –
Pathogen Diversity
No pathogens 16.4% (12.4–21.3) 14.8% (7.5–27.3) 16.9% (10.2–26.7) 10.6% (4.4–23.6) 20.0% (12.7–30.0)
Single pathogen 38.3% (32.6–44.3) 35.2% (23.5–49.0) 41.0% (30.8–52.0) 21.3% (11.6–35.6) 47.1% (36.6–57.8)
2 pathogens 25.6% (20.8–31.2) 18.5% (10.1–31.5) 26.5% (18.0–37.2) 36.2% (23.5–51.1) 23.5% (15.6–33.8)
3 pathogens 14.9% (11.1–19.7) 22.2% (12.9–35.5) 12.0% (6.5–21.1) 23.5% (13.2–37.9) 8.2% (3.9–16.4)
4 pathogens 3.7% (2.0–6.8) 7.4% (2.7–18.5) 3.6% (1.2–10.8) 6.4% (2.0–18.5) –
5 pathogens 0.7% (0.2–2.9) – – 2.1% (0.3–1.4) 1.2% (0.2–8.1)
6 pathogens – – – – –
7 pathogens – – – – –
8 pathogens 0.4% (0.1–2.6) 1.9% (0.2–12.5) – – –
Table 2 Mean number of pathogens detected among enrolled CTC patients, stratified by age and sex
Count Data Model Estimated No. of Pathogens Carried Standard Deviation Unadjusted IRR* (95% CI) p Value
Total 1.56
All males 1.60 1.23 1.05 (0.88–1.26) 0.35
Boys 1–15 years 1.83 1.46 1.47 (1.13–1.92) 0.004
Men 16–81 years 1.45 1.03 1.16 (0.93–1.45) 0.19
All females 1.50 1.12 Reference**
Girls 1–15 years 2.0 0.95 1.60 (1.27–2.02) < 0.001
Women 16–81 years 1.52 1.09 Reference
*denotes the incident rate ratio;
**All females are the reference group for all males as sex is a separate variable to the age group
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carriers for multiple pathogens i.e. two or more enteric
pathogens. Up to eight different pathogens were de-
tected in a single patient. Pathogen diversity was highest
among male and female children (age 1–15 years) and
lowest among adult women (age 16–81 years).
Our results on cholera confirmation are similar to
those of the multi-site AFRICHOL study [31] and sug-
gest that cholera burden in the DRC may be lower than
previously estimated. Our PCR results with regard to
cholera detection are comparable to results obtained
using a commercial RDT among a similar study popula-
tion [19]. Despite finding no evidence for a significant
difference between these two methods (McNemar’s test
p = 0.7), 7% of study participants were PCR positive but
RDT negative and 6% were RDT positive and PCR nega-
tive. This could be explained by the performance of the
two tests as neither are a gold standard; xTAG GPP
methods have 100% specificity but do not have a vali-
dated sensitivity (Luminex Corporation, Austin TX,
USA) and Crystal VC RDT has a cholera detection sensi-
tivity and specificity of 93 and 91% respectively (Crystal
VC, Span Diagnostics, Surat, India). The discrepancies
between the PCR and RDT results could also partly be
due to the detection of non-toxigenic V. cholerae O1 by
RDT, although, the proportion of these strains is esti-
mated to be less than 5% in similar contexts [20]. Dis-
crepancies may also be caused by the detection of
toxigenic non-O1/O139 V. cholerae by PCR. However,
the likelihood of having toxigenic strains of serogroups
other than O1 or O139, even though they have been im-
plicated as a cause of cholera-like outbreaks [32, 33], is
low and has not been reported in a similar epidemio-
logical context. The majority of concordant pairs in
RDT/PCR results suggests nonetheless that the V. cho-
lerae strains detected were toxigenic O1.
A recent multi-country study for the etiology of mod-
erate to severe diarrhea in children under five years
showed the proportion of diarrheal disease attributable
to V. cholerae increased as age increased [2, 34]. Another
study for the change in enteric pathogen prevalence dur-
ing floods showed the prevalence of toxigenic V. cho-
lerae was higher in adults than children [35]. In our own
study, we found a higher proportion of V. cholerae path-
ogens in adults than in children, and children carried
more pathogens than adults. Current literature also sug-
gests that enteric infections can be asymptomatic as seen
in the re-analysis of the GEMS case-control study [34,
36] Infections with Campylobacter, Cryptosporidium,
and ETEC were often not associated with diarrhea in
children under five, and the same study indicates diar-
rhea could be explained by the combined presence of
multiple pathogens or that the severity of a diarrheal ill-
ness increases when multiple pathogens are present [34,
36, 37]. In the re-analysis of the MAL-ED birth-cohort
study, clinical presentation of illness was also modified
when a child had co-infections [38]. Furthermore, both
ETEC and Shigella have been shown to have long-term
growth deficits and Cryptosporidium can affect growth
even in asymptomatic people [38, 39]. Our results show
a mean number of nearly 1.6 pathogens in participants
of all ages and all considered as suspected cholera cases.
Regardless of causality, these pathogens potentially have
positive associations with each other and may increase
the severity of diarrheal symptoms.
ETEC and V. cholerae represented the majority of de-
tected pathogens in our participants. Both cause profuse
watery diarrhea and severe dehydration and are often
mis-diagnosed in the absence of laboratory diagnosis
[35]. The pathogens included in this study share fecal-
oral transmission pathways, either water-borne or water-
washed [40] and continued improvements on WASH in-
frastructure and access to safe drinking water could re-
duce the main transmission routes of many of these
pathogens. Only one case of rotavirus was detected in
our samples, although the burden attributed to rotavirus
in LMICs is reportedly high [1]. Two possible reasons
for this are: rotavirus most commonly infects children
under the age of five, an age group for which we had
few participants; preservation on FTA Elute cards and
storage may also have had more detrimental effect on
viral DNA/RNA than on other pathogen’s nucleic acids.
Limitations
There are a number of limitations to this study. First,
our study only included people admitted to the CTC
and, therefore, does not capture symptomatic cholera
cases who do not seek care or asymptomatic carriers
[10, 41]. Secondly, we opted to use rectal swabs for sam-
pling, instead of direct stool, to mitigate the high risk of
cross-contamination or contact with chlorine. A previ-
ous study found rectal swabs had similar detection rates
when compared to direct stool samples during PCR ana-
lysis [42]. Storing samples on FTA elute cards for the
Luminex PCR assay has yet to be validated; although,
multiple studies have described FTA elute cards as a
comparable preservation method when compared to
fresh and frozen samples [21, 43]. Literature also sug-
gests there are no signs of nucleic acid degradation with
short-term storage on elute cards; however prolonged
preservation, humidity, and high temperatures may
negatively impact nucleic acid preservation, particularly
with RNA [21, 43–45]. In our study, viral pathogens
were lower than expected, which could be attributed to
viral nucleic acid degradation. This may explain why
rotavirus was detected in only one sample. Therefore,
negative results should be interpreted with caution.
Giardia was found by the manufacturer to cross-react
with other organisms in stool samples and accurate
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detection would have required a follow-up identification
method for all positive samples, which was not possible
in our study. Therefore, Giardia detections results were
not included in the statistical analysis. No fungal patho-
gens are targeted by the Luminex xTAG GPP. Luminex
xTAG® GPP detects toxigenic V. cholerae strains while
Crystal® VC RDT detects O1/O139 antigens of V. cho-
lerae strains. Therefore, we were not able to conclude
whether testing performance or variety of V. cholerae
strains are leading to discordant results between both
methods and we may not be detecting non-toxigenic
non-O1/non-O139 strains that can be responsible for
diarrhea. Finally, to determine the pathogens truly asso-
ciated with acute diarrheal disease amongst admitted
CTC patients would have required a different study de-
sign and the use of quantitative PCR methods to assess
the etiological quantity of detected pathogens [46]; how-
ever, in the circumstance of acute diarrhea, single patho-
gen detection is likely sufficient to determine enteric
infections [47] as symptomatic individuals typically shed
a higher quantity of pathogens [47–49].
Conclusions
Our finding that more than half the patients admitted to
a CTC were not positive for cholera by stool-based PCR
and RDT assays are consistent with previous results in
DRC and other cholera endemic areas of sub-Sahara Af-
rica. However, the prevalence of the assessed enteric
pathogens was high among patients admitted to the
Uvira CTC with 84% having at least one of the 15
assessed pathogens, and 45% carrying multiple patho-
gens. Our findings lend support to the current strategy
of the DRC Ministry of Health for the prevention and
control of cholera, which targets “hotspot” areas such as
North and South Kivu, and encourages future actions to
continue with a comprehensive strategy that includes
both improved water, sanitation and hygiene and effect-
ive and timely treatment of cases.
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